Corneal defect
1 paper
Trial sponsors
1 trialPhase 450 people
University of Illinois at Chicago
1 trialEarly phase 19 people
Latest
Graefe's Archive for Clinical and Experimental Ophthalmology
Nicotinamide mononucleotide, a potential future treatment in ocular diseases
ReviewInterventions